azathioprine has been researched along with Embolism in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Embolism: Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Azathioprine treatment reduced the aCL titer in the other patient, without fully normalizing it." | 1.28 | Primary antiphospholipid syndrome (PAPS). Two case reports and therapeutic implications. ( Engler, H; Lang, B; Peter, HH; Rump, JA, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rump, JA | 1 |
| Lang, B | 1 |
| Engler, H | 1 |
| Peter, HH | 1 |
1 other study available for azathioprine and Embolism
| Article | Year |
|---|---|
Primary antiphospholipid syndrome (PAPS). Two case reports and therapeutic implications.
Topics: Adolescent; Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Embolism; Fe | 1991 |